Dirk Arnold, MD, PhD, medical director, Asklepios Tumour Biology Centre, discusses the trial design of a study comparing amivantamab with standard chemotherapy to potentially improve treatment ...

Enflonsia is the first FDA-approved respiratory syncytial virus (RSV) preventative for infants, regardless of weight, according to the news release.

Merck announced yesterday that the US Food and Drug Administration (FDA) has approved its monoclonal antibody vaccine ...

The head of the Department of Health and Human Services fired all the members of a committee advising the CDC on vaccine ...

Researchers say people with schizophrenia are facing an "epidemic" of obesity-related diseases, with weight gain a common ...

A Ugandan doctor is being awarded an honorary doctorate from Western University on Tuesday for her ongoing work to treat and ...

This year's Brian G.M. Durie Outstanding Achievement Awardee is Sonja Zweegman, MD, PhD, Head of the Department of Hematology ...

The FDA has accepted for Priority Review the New Drug Application for TransCon CNP (navepegritide) for the treatment of children with achondroplasia.

Experts cite the steady march of state legalization — use by older people is highest in those states — while surveys show ...

NORCROSS, Ga., June 10, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3 for patients with MASH cirrhosis and portal ...

Merck & Co – known as MSD outside the US and Canada – has announced that its respiratory syncytial virus (RSV) preventive ...

The global population is aging rapidly, with the number of people aged 65 and older expected to double by 2050. This demographic shift is driving a s ...